Navigation Links
Transcept Pharmaceuticals to Participate in Middle-of-the-Night (MOTN) Insomnia Investor Panel
Date:10/1/2007

CEO Glenn A. Oclassen to Join Sleep Experts in Panel Hosted by Natixis

Bleichroeder

PT. RICHMOND, Calif., Oct. 1 /PRNewswire/ -- Transcept Pharmaceuticals, Inc. today announced that Glenn A. Oclassen, President and Chief Executive Officer, will participate in a panel focused on middle-of-the-night (MOTN) insomnia at the Natixis Bleichroeder "Hidden Gems" Healthcare Conference.

Date: Monday, October 8, 2007

Panel Discussion: 3:45 p.m. ET

Company Presentation: 4:45 p.m. ET

Location: The Carlton Hotel at 88 Madison Avenue, New York, NY

Mr. Oclassen commented, "This is the first panel sponsored by the investment community to discuss the form of insomnia that is characterized by patients who awaken in the middle of the night and have difficulty returning to sleep. According to a recent survey conducted by the Stanford Sleep Epidemiology Research Center, it is estimated that up to 35% of Americans over the age of 18 suffer primarily from this and related forms of sleep disorder. Despite this large patient population, there is no pharmaceutical agent currently approved to treat this common sleep problem."

"Transcept is developing Intermezzo(TM) (zolpidem tartrate lozenge) for the treatment of such MOTN insomnia. In a recently completed Phase 3 sleep laboratory study, Intermezzo(TM) met the primary endpoint of decreasing sleep onset after a middle of the night awakening, without next day residual effects. I look forward to participating in this panel with these respected sleep experts and raising awareness of this aspect of insomnia."

The MOTN insomnia panel will be co-hosted by Corey Davis, Ph.D., and Jon LeCroy, M.D. of Natixis Bleichroeder. The panel of sleep experts will include Martin B. Scharf, PhD, Director, Center for Research in Sleep Disorders, Cincinnati, Ohio and Gary K. Zammit, Ph.D., Director of the Sleep Disorders Institute at St. Luke's/Roosevelt Hospital, NYC.

<
'/>"/>
SOURCE Transcept Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Deltanoid Pharmaceuticals begins phase II osteoporosis study
2. The Coming of Biotech Generic Pharmaceuticals
3. Bruker Participates in Dutch Funded Super Microscope Project
4. Venture Investors early-stage fund grows to $115 million
5. Investor warns of angel-venture funding gap
6. Brazilian bio-industry should impress American investors
7. Investors raise $25 million for biodiesel plant
8. Bio-energy and cleantech grab attention of investors
9. Venture Investors to open Michigan office
10. Early-stage executives hear from investors
11. Commerce qualifies seven for investor tax credits

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... , REYKJAVIK, Iceland, November 24...Nasdaq: DCGN ) today announced the approval of all... Court for the District of Delaware,(the "Bankrupt...ition for,relief under Chapter 11 of the United St..., The orders issued by the Bankruptcy Court...
(Date:11/24/2009)..., SEATTLE, Nov. 24 Blue Marble Ene... Odessa Public Development Authority (OPDA) were r...ommunity Economic Revitalization Board (CERB) in a...,s first specialty biochemical biorefinery in Linc...ificantly speed the development of our biorefinery...
(Date:11/24/2009)..., DUBLIN, November 24 /PRNewswire-FirstCall/ ...al specialty biopharmaceutical company, today,anno...Medicines Agency for,velaglucerase alfa, the compa... the treatment of Type 1 Gaucher disease. This is ...alfa that has been submitted, with previous,submis...
(Date:11/24/2009)... Program Connects Customers with Pa...llected with DNA Genotek Products , ... DNA Genotek , a leading provider of products for...reparation, today announced its new global partner...nts for DNA Genotek,s partner community and is des...
Breaking Biology Technology:deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 4DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3
...Jones II named Vice President and General Manager ...lion prescriptions a week, FRANKLIN LAKES, N.J., ...), one of the nation,s leading pharmacy benefit,ma... Whitestown, Indiana,will be the home of world,s l...g a nearly year-long search that spanned 48 states...
...Mass., Dec. 18 ActivBiotics, Inc. today,announced...r its clinical,trial of Rifalazil failed in periph...ling all or substantially all of its assets on an ...t of Creditors, process. The,Assignee of the asset...s,below). The bidding for the assets, which may be...
...Mich., Dec. 18 Stryker Corporation,(NYSE: SYK ) ...ednesday,January 23, 2008 at 4:30 p.m., Eastern Ti... the quarter and year ended December 31, 2007 and,...or the quarter and year,ended December 31, 2007 wi... MacMillan, President and Chief Executive Officer,...
Other Biology Technology:Medco Chooses AllPoints at Anson in Whitestown, Indiana as Site for the World's Largest, Most-Advanced Automated Pharmacy 2Medco Chooses AllPoints at Anson in Whitestown, Indiana as Site for the World's Largest, Most-Advanced Automated Pharmacy 3Medco Chooses AllPoints at Anson in Whitestown, Indiana as Site for the World's Largest, Most-Advanced Automated Pharmacy 4Medco Chooses AllPoints at Anson in Whitestown, Indiana as Site for the World's Largest, Most-Advanced Automated Pharmacy 5ActivBiotics Sells Proprietary Assets, Including Drug Product Candidates 2ActivBiotics Sells Proprietary Assets, Including Drug Product Candidates 3Stryker to Host Conference Call on January 23, 2008 2
(Date:11/24/2009)..., 2009) -- The Wildlife Conservation Society (WCS)...remaining population of Siberian tigers has likely...poaching and habitat loss. , WCS say... what needs to be done to protect remaining popula... The report was released by the Siberian Tiger Mon...
(Date:11/24/2009)...h . , The presence of increased body fat, an...es in the blood, hinders the loss and maintenance ...the University of Navarra conducted by Estbaliz Go...cy. , The project, entitled "A nutrigenetic and ...ody weight and inflammation," examines how the ind...
(Date:11/23/2009)...me of day matters to forest trees dealing with dro...rch team led by Professor Malcolm Campbell, Univer...esearch and colleagues in the department of cell a... Capitalizing on their previous work to decode the...ined how poplar trees use their 45,000 genes to re...
Breaking Biology News(10 mins):Report shows dramatic decline in Siberian tigers 2It can be predicted the reaction obese patients will have to a diet 2Time of day matters to thirsty trees, U of T researcher discovers 2Vertical Measures Announces its Version of Healthcare Reform by Giving Away 5K in Internet Marketing Services 58840 1Vertical Measures Announces its Version of Healthcare Reform by Giving Away 5K in Internet Marketing Services 58840 2Vertical Measures Announces its Version of Healthcare Reform by Giving Away 5K in Internet Marketing Services 58840 3Child burn injuries down significantly 58836 1Child burn injuries down significantly 58836 2Child burn injuries down significantly 58836 3AMERIGROUP Foundation Supports Groundbreaking on Grommet Island Park for People With Disabilities 14342 1AMERIGROUP Foundation Supports Groundbreaking on Grommet Island Park for People With Disabilities 14342 2
...ters in 11 states are the latest members of the Na...ional Science Award (CTSA) consortium. Creating a ...ross the nation, the consortium is working to redu... become treatments for patients and to engage comm...ulfilling the critical need to train the next gene...
... cyclic increase and decrease of jellyfish populat...ne of the U.S.,s most productive fisheries--into v...dy shows that the availability of food for jellyfi...jellyfish population, even while other factors, su...nued growth. , These results indicate that "antic...
...ghout the overlooked depths of Lake Michigan and o...rapidly disappearing. , Until recently, the anima...oreia - was a major food source for commercially i... fish upon which salmon, trout and walleye rely. ,... a quest to explain their population freefall, whi...
Other Biology News:NIH expands national consortium dedicated to transforming clinical and translational research 2NIH expands national consortium dedicated to transforming clinical and translational research 3Scientists discover stinging truths about jellyfish blooms in the Bering Sea 2Scientists discover stinging truths about jellyfish blooms in the Bering Sea 3A Great Lakes mystery: The case of the disappearing species 2A Great Lakes mystery: The case of the disappearing species 3A Great Lakes mystery: The case of the disappearing species 4
Human HGF, Unconjugated from R&D Systems
Anti-alpha1-Antitrypsin Monoclonal Antibody, Unconjugated from CHEMICON
Senescence Colorimetric Assay Kit from BioVision
Mouse LIGHT / TNFSF14, Unconjugated from R&D Systems
Biology Products: